ArticleSchizophrenia bulletin2018
Clinical High Risk Controversies and Challenge for the Experts.
Article in Schizophrenia bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Baseline data of a sequential multiple assignment randomized trial (STEP study).Early intervention in psychiatry · 2022Trial
- Gender differences in semantic facilitation and verbal recall in schizotypal personality disorder.Schizophrenia (Heidelberg, Germany) · 2026Article
- Clinical symptoms of the prodromal stage preceding serious mental illness in Taiwanese young adults: a qualitative study.BMC psychiatry · 2025Article
- Clinical and neurocognitive profiles of a combined clinical high risk for psychosis and clinical control sample: latent class analysis.BJPsych open · 2024Article
- Metacognition as a Transdiagnostic Determinant of Recovery in Schizotypy and Schizophrenia Spectrum Disorders.Behavioral sciences (Basel, Switzerland) · 2024Review
- MK-Curve improves sensitivity to identify white matter alterations in clinical high risk for psychosis.NeuroImage · 2021Article
- Computerized Assessment of Psychosis Risk.Journal of psychiatry and brain science · 2021Article
- Sixth Kraepelin Symposium-Understanding and Treating Cognitive Impairment and Depression in Schizophrenia and Affective Disorders.Schizophrenia bulletin · 2019Article
- Metacognitive Therapy for Individuals at High Risk of Developing Psychosis: A Pilot Study.Frontiers in psychology · 2019Article
- Rethinking the Psychosis Threshold in Clinical High Risk.Schizophrenia bulletin · 2019Article
- Emerging and evolving concepts in the pathobiology and treatment of psychosis.CNS neuroscience & therapeutics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.